Benefit vs potential harm of genome-wide prenatal cfDNA testing requires further investigation and should not be dismissed based on current data

M.N. Bekker; L. Henneman; M.V.E. Macville; E.A. Sistermans; R.J.H. Galjaard

doi:10.1002/uog.22030

Benefit vs potential harm of genome-wide prenatal cfDNA testing requires further investigation and should not be dismissed based on current data

M.N. Bekker^*, L. Henneman, M.V.E. Macville, E.A. Sistermans, R.J.H. Galjaard

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	695-696
Number of pages	2
Journal	Ultrasound in Obstetrics & Gynecology
Volume	55
Issue number	5
DOIs	https://doi.org/10.1002/uog.22030
Publication status	Published - 1 May 2020

Keywords

maternal blood
MATERNAL BLOOD

Access to Document

10.1002/uog.22030

Cite this

@article{2c4bf8c29fe74942a13e432a4af7a3f2,

title = "Benefit vs potential harm of genome-wide prenatal cfDNA testing requires further investigation and should not be dismissed based on current data",

keywords = "maternal blood, MATERNAL BLOOD",

author = "M.N. Bekker and L. Henneman and M.V.E. Macville and E.A. Sistermans and R.J.H. Galjaard",

note = "Funding Information: All authors are affiliated with the Dutch NIPT Consortium that initiated the TRIDENT studies in The Netherlands. The TRIDENT studies are supported by a grant from The Netherlands Organization for Health Research and Development (ZonMw, No. 543002001).",

year = "2020",

month = may,

day = "1",

doi = "10.1002/uog.22030",

language = "English",

volume = "55",

pages = "695--696",

journal = "Ultrasound in Obstetrics & Gynecology",

issn = "0960-7692",

publisher = "Wiley",

number = "5",

}

Benefit vs potential harm of genome-wide prenatal cfDNA testing requires further investigation and should not be dismissed based on current data. / Bekker, M.N.; Henneman, L.; Macville, M.V.E. et al.
In: Ultrasound in Obstetrics & Gynecology, Vol. 55, No. 5, 01.05.2020, p. 695-696.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - Benefit vs potential harm of genome-wide prenatal cfDNA testing requires further investigation and should not be dismissed based on current data

AU - Bekker, M.N.

AU - Henneman, L.

AU - Macville, M.V.E.

AU - Sistermans, E.A.

AU - Galjaard, R.J.H.

N1 - Funding Information: All authors are affiliated with the Dutch NIPT Consortium that initiated the TRIDENT studies in The Netherlands. The TRIDENT studies are supported by a grant from The Netherlands Organization for Health Research and Development (ZonMw, No. 543002001).

PY - 2020/5/1

Y1 - 2020/5/1

KW - maternal blood

KW - MATERNAL BLOOD

U2 - 10.1002/uog.22030

DO - 10.1002/uog.22030

M3 - Comment/Letter to the editor

C2 - 32356934

SN - 0960-7692

VL - 55

SP - 695

EP - 696

JO - Ultrasound in Obstetrics & Gynecology

JF - Ultrasound in Obstetrics & Gynecology

IS - 5

ER -